FindTrial
Sign In

Interferon alpha-2b

DRUG6 trials

Sponsors

The University of Hong Kong, National Cancer Institute, Milan, Ohio State University Comprehensive Cancer Center, M.D. Anderson Cancer Center, Jules Bordet Institute

Conditions

Advanced CancerGastro-intestinal Neuroendocrine TumorsHepatic ResectionHepatitis C Virus InfectionHepatocellular CarcinomaInterferon TreatmentLiver CirrhosisMelanoma

Phase 1

Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC
CompletedNCT00234182
The University of Hong KongHepatocellular Carcinoma
Start: 2000-01-31End: 2004-12-31Target: 84Updated: 2005-12-01
Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced Malignancies
CompletedNCT00629200
M.D. Anderson Cancer CenterAdvanced Cancer, Solid Tumors
Start: 2006-09-13End: 2010-02-10Updated: 2018-11-15
Systemic Therapy With Interferon, Interleukin-2 and BRAF Inhibitor
CompletedNCT01603212
M.D. Anderson Cancer CenterMelanoma
Start: 2013-07-18End: 2017-07-05Updated: 2019-05-21

Phase 2

Interferon Alpha-2b (Intron A) for Metastatic or Unresectable Clear Cell Renal Carcinoma
WithdrawnNCT00293527
Ohio State University Comprehensive Cancer CenterRenal Cancer
End: 2006-11-30Updated: 2013-05-23

Phase 3

Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis
CompletedNCT00273247
National Cancer Institute, MilanHepatic Resection, Hepatitis C Virus Infection, Hepatocellular Carcinoma +2
Start: 1998-06-30End: 2005-09-30Target: 150Updated: 2006-01-09
Randomized Phase III of PRRT Versus Interferon
WithdrawnNCT01860742
Jules Bordet InstituteGastro-intestinal Neuroendocrine Tumors
Start: 2014-12-31End: 2016-10-31Updated: 2016-04-05